PTGX logo

Protagonist Therapeutics, Inc. (PTGX) Cash From Investing

Annual CFI:

-$299.48M-$260.23M(-662.86%)
December 31, 2024

Summary

  • As of today, PTGX annual cash from investing is -$299.48 million, with the most recent change of -$260.23 million (-662.86%) on December 31, 2024.
  • During the last 3 years, PTGX annual cash from investing has fallen by -$283.62 million (-1788.29%).
  • PTGX annual cash from investing is now -427.42% below its all-time high of $91.47 million, reached on December 31, 2022.

Performance

PTGX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXcash flow metrics

Quarterly CFI:

$54.81M+$149.21M(+158.06%)
June 30, 2025

Summary

  • As of today, PTGX quarterly cash from investing is $54.81 million, with the most recent change of +$149.21 million (+158.06%) on June 30, 2025.
  • Over the past year, PTGX quarterly cash from investing has increased by +$142.93 million (+162.20%).
  • PTGX quarterly cash from investing is now -4.30% below its all-time high of $57.27 million, reached on September 30, 2022.

Performance

PTGX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXcash flow metrics

TTM CFI:

-$257.03M+$142.93M(+35.74%)
June 30, 2025

Summary

  • As of today, PTGX TTM cash from investing is -$257.03 million, with the most recent change of +$142.93 million (+35.74%) on June 30, 2025.
  • Over the past year, PTGX TTM cash from investing has dropped by -$100.13 million (-63.82%).
  • PTGX TTM cash from investing is now -322.73% below its all-time high of $115.40 million, reached on September 30, 2022.

Performance

PTGX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

PTGX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-662.9%+162.2%-63.8%
3Y3 Years-1788.3%+57.8%-2015.5%
5Y5 Years-457.6%+1160.0%-782.7%

PTGX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-427.4%at low-4.3%+126.3%-322.7%+35.7%
5Y5-Year-427.4%at low-4.3%+126.3%-322.7%+35.7%
All-TimeAll-Time-427.4%at low-4.3%+126.3%-322.7%+35.7%

PTGX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$54.81M(+158.1%)
-$257.03M(+35.7%)
Mar 2025
-
-$94.40M(-982.0%)
-$399.96M(-33.5%)
Dec 2024
-$299.48M(-662.9%)
-$8.72M(+95.8%)
-$299.48M(+14.9%)
Sep 2024
-
-$208.71M(-136.9%)
-$352.05M(-124.4%)
Jun 2024
-
-$88.12M(-1551.5%)
-$156.89M(-264.8%)
Mar 2024
-
$6.07M(+109.9%)
-$43.01M(-9.6%)
Dec 2023
-$39.26M(-142.9%)
-$61.29M(-352.0%)
-$39.26M(-251.2%)
Sep 2023
-
-$13.56M(-152.6%)
$25.96M(-73.2%)
Jun 2023
-
$25.76M(+162.2%)
$96.80M(-8.5%)
Mar 2023
-
$9.83M(+149.7%)
$105.77M(+15.6%)
Dec 2022
$91.47M(+676.7%)
$3.94M(-93.1%)
$91.47M(-20.7%)
Sep 2022
-
$57.27M(+64.9%)
$115.40M(+760.0%)
Jun 2022
-
$34.73M(+876.0%)
$13.42M(+199.1%)
Mar 2022
-
-$4.48M(-116.1%)
-$13.54M(+14.6%)
Dec 2021
-$15.86M(+82.6%)
$27.87M(+162.3%)
-$15.86M(+86.6%)
Sep 2021
-
-$44.71M(-675.2%)
-$118.13M(+7.4%)
Jun 2021
-
$7.77M(+214.4%)
-$127.54M(+9.2%)
Mar 2021
-
-$6.79M(+90.9%)
-$140.49M(-54.4%)
Dec 2020
-$90.97M
-$74.40M(-37.5%)
-$90.97M(-212.4%)
Sep 2020
-
-$54.12M(-946.6%)
-$29.12M(-313.9%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$5.17M(-112.1%)
-$7.03M(+53.4%)
Mar 2020
-
$42.73M(+440.4%)
-$15.09M(+71.9%)
Dec 2019
-$53.71M(-2527.0%)
-$12.55M(+60.8%)
-$53.71M(-46.7%)
Sep 2019
-
-$32.04M(-142.3%)
-$36.61M(-784.4%)
Jun 2019
-
-$13.22M(-421.9%)
$5.35M(-81.0%)
Mar 2019
-
$4.11M(-9.7%)
$28.16M(+1172.7%)
Dec 2018
$2.21M(-86.0%)
$4.55M(-54.1%)
$2.21M(-8.4%)
Sep 2018
-
$9.92M(+3.4%)
$2.42M(+129.2%)
Jun 2018
-
$9.59M(+143.9%)
-$8.27M(-73.4%)
Mar 2018
-
-$21.84M(-559.7%)
-$4.77M(-130.2%)
Dec 2017
$15.82M(+126.7%)
$4.75M(+715.5%)
$15.82M(+129.7%)
Sep 2017
-
-$772.00K(-105.9%)
-$53.25M(-9.6%)
Jun 2017
-
$13.09M(+1147.4%)
-$48.60M(+28.2%)
Mar 2017
-
-$1.25M(+98.1%)
-$67.72M(-14.2%)
Dec 2016
-$59.33M(-617.9%)
-$64.33M(-1756.2%)
-$59.33M(-1821.2%)
Sep 2016
-
$3.88M(+164.4%)
-$3.09M(+55.7%)
Jun 2016
-
-$6.03M(-184.4%)
-$6.97M(-643.3%)
Mar 2016
-
$7.15M(+188.4%)
-$938.00K(+88.4%)
Dec 2015
-$8.26M(-2663.9%)
-$8.09M(>-9900.0%)
-$8.09M(>-9900.0%)
Mar 2015
-
-$5000.00
-$5000.00
Dec 2014
-$299.00K
-
-

FAQ

  • What is Protagonist Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Protagonist Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Protagonist Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Protagonist Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of PTGX is -$299.48M

What is the all-time high annual cash from investing for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high annual cash from investing is $91.47M

What is Protagonist Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, PTGX annual cash from investing has changed by -$260.23M (-662.86%)

What is Protagonist Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of PTGX is $54.81M

What is the all-time high quarterly cash from investing for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high quarterly cash from investing is $57.27M

What is Protagonist Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, PTGX quarterly cash from investing has changed by +$142.93M (+162.20%)

What is Protagonist Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of PTGX is -$257.03M

What is the all-time high TTM cash from investing for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high TTM cash from investing is $115.40M

What is Protagonist Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, PTGX TTM cash from investing has changed by -$100.13M (-63.82%)
On this page